                                GEORGE P. COBB
Affiliation: Professor, Department of Environmental Science, Baylor University, Waco, Texas. 
Expertise: Environmental chemistry; analytical chemistry; and exposure assessment. 
Education: PhD in Chemistry, University of South Florida, Gainesville, Florida; BS in Chemistry, College of Charleston, Charleston, South Carolina.
Experience Summary: Dr. George Cobb is a professor of Environmental Science and Department Chairman at Baylor University. He has 30+ years of experience assessing fate and effects of chemicals in the environment. Dr. Cobb has published over 130 peer reviewed journal articles in this area of inquiry and has successfully assessed adverse effects that contaminants cause in organisms, both in environment and controlled laboratory studies. Successful field assessments have included normal-use pesticide applications, National Priorities List sites, and state and municipal air and water quality. Most recently, Dr. Cobb's group has emphasized: nanomaterial alteration of amphibian development and of rice accumulation of metal toxicants; interactions of toxicants and light to induce stress; airborne steroid movement from concentrated animal feeding operations; explosive transformation in mammals; and ultra-high-resolution Mass Spectrometry screening. Within the American Chemical Society, he has been named a Fellow, as well as serving as the immediate past Chairman of the Environmental Chemistry Division, and a member of the Committee for Environmental Improvement. Dr. Cobb is a former President of the Society of Environmental Toxicology and Chemistry. He currently serves as an Editor for the Journal Environmental Toxicology and Chemistry. 
Panel Experience: U.S. Environmental Protection Agency (U.S. EPA) Science Advisory Board: Chemical Assessment Advisory Committee: IRIS Assessment for Hexahydro-1,3,5- trinitro1,3,5-triazine (2016-2017). Toxic Substance Control Act Science Advisory Committee on Chemicals (TSCA SACC) on PBT chemicals (2018). U.S. EPA's Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Scientific Advisory Panel (15 reviews completed, Rapporteur 4, 1999 - present) , addressing topics related to ecological and human health risk assessments, from the inception of Ecological Committee on FIFRA Risk Assessment Methods (ECOFRAM ) [1999] through recent RNAi assessments for crop protection.
                                       
                                       
                                       
                                       
                                       
                                       
                                KENNY S. CRUMP
Affiliation: No current affiliation.
Expertise: Research in developing and applying statistical methods for quantitative assessment of health risks from exposures to toxic substances.  
Education: PhD in Mathematics, Montana State University, Bozeman, Montana; BA in Mathematics, University of Denver, Denver, Colorado; BS in Electrical Engineering, Louisiana Tech University, Ruston, Louisiana.
Experience Summary: Dr. Kenny Crump worked for various consulting firms (1980-2010), focusing on developing and applying statistical methods to bioassay data and epidemiological data on risks to health from exposures to toxic substances.  Prior to that time he spent 14 years (1966-1980) teaching mathematics and conducting research at Louisiana Tech University.  He is currently conducting unfunded research.  He is a Fellow of both the American Statistical Association and the Society for Risk Analysis and received distinguished achievement awards from both of these organizations.  He is an author of more than 150 peer reviewed publications and book chapters.  
Panel Experience: Dr. Crump served on the U. S. Congress Office of Technology Assessment Tolerance Advisory Panel  --  Environmental Contaminants in Food (1978-1979), the Province of Ontario Advisory Panel on 2,4-D (1984-1987), the U. S. EPA Science Advisory Board (1991-1997), the U. S. EPA Research Strategies Advisory Committee (1995-1997), the National Center for Toxicological Research Science Advisory Board (1991-1995), the National Institute of Environmental Health Sciences Board of Scientific Counselors (1995), the Mickey Leland National Urban Air Toxics Research Center Science Advisory Panel (1995-1999), the Royal Society of Canada Expert Panel on Asbestos (1996), the California EPA Office of Environmental Health Hazard Assessment (OEHHA) Risk Assessment Methodology Review Committee (1995-1996), the Office of Science and Technology Policy Workshop on Methylmercury Statistics Panel (1998), the U. S. EPA Dioxin Reassessment Review Committee (2000-2001),  the National Toxicology Program Board of Scientific Counselors (2005-2008), the Health Canada Chrysotile Asbestos Expert Panel (2007-2008) and the U. S. EPA's Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Scientific Advisory Panel (SAP) on glyphosate (2016-2017).  He served on six National Academy of Science Committees (1979-1980, 1981-1982, 1989-1993, 2006-2009, 2014, 2015-2017). Dr. Crump also served as an advisor to the Joint Food and Agricultural Organization and the World Health Organization (FAO/WHO) Expert Committee on Food Additives (JECFA) (2001).
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                               DAVID A. EASTMOND
                                       
Affiliation: Professor of Cell Biology and Toxicologist, University of California, Riverside, California. 

Expertise: Research on the mechanisms of genotoxicity and carcinogenesis of environmental agents and its application in assessing the risk of chemicals. 

Education: PhD in Environmental Health Sciences, University of California, Berkeley, California; MS and BS in Entomology, Brigham Young University, Provo, Utah.

Experience Summary: Dr. David Eastmond is a professor and toxicologist in the Department of Molecular, Cell and Systems Biology at the University of California (UC), Riverside, where he teaches and conducts research in the areas of toxicology and risk assessment. He also served at UC Riverside as Department Chair (2008 - 2017) and Environmental Toxicology Graduate Program Chair (1999 - 2004; 2005 - 2008). His research has a specific focus on environmental and public health toxicology, with an emphasis on understanding the mechanisms involved in genotoxicity and chemical carcinogenesis, and on assessing risks posed to humans from environmental agents. Dr. Eastmond served as the President of the Environmental Mutagen Society (2003 -  2004), as a Jefferson Science Fellow in the US State Department (2004 - 2005), as a Council member of the National Council on Radiation Protection and Measurements (2004 - 2010) and is a Fellow of the Collegium Ramazzini (2011 - present). He has served on the editorial boards of the journals Mutation Research, Genetic Toxicology and Environmental Mutagenesis (1994 - present), Toxicological Sciences (2007 - 2015) and Chemico-Biological Interactions (1998 - 2001). 

Panel Experience: Dr. Eastmond is currently a member of the EPA Chemical Assessment Advisory Committee (2013 - 2019), the Organisation for Economic Cooperation and Development (OECD) Genotoxicity Test Guidelines Working Group (2010 - present), the California EPA Carcinogen Identification Committee (1999 -  present), and the World Health Organization (WHO) Committee to Develop Guidance on Evaluating the Genotoxicity of Compounds in Food for Human Health Risk Assessment (2017 - present). He previously served on the Joint Food and Agricultural Organization (FAO) and the World Health Organization (FAO/WHO) Meeting on Pesticide Residues (JMPR) working group as an invited expert (2015-16), as Food and Agriculture Organization (FAO/WHO) Meeting Chair (2017), and as Chair of the WHO group (2018). He co-chaired the Risk of Aneugens working group for the International Working Group on Genotoxicity Testing (2016 - 2019) and served as a member of the Aliso Canyon Gas Leak Independent Expert Scientific Advisory Panel for California EPA (2016). He also served on the National Toxicology Program Board of Scientific Counselors as a member (2009 - 2012) and as Chair (2011 - 2012). He co-chaired the Expert Panel on Genotoxicity Testing of Pharmaceuticals for the U.S. Food and Drug Administration (2010). He also chaired the WHO International Programme on Chemical Safety (IPCS) for the harmonization of methods for the Prediction and Quantification of Human Carcinogenic/Mutagenic Hazard Committee (2007 - 2008) and served on working groups for the International Agency for Research on Cancer (2004, 2007, and 2008).
                                LAURA C. GREEN
Affiliation: Senior Toxicologist and President, Green Toxicology LLC, Brookline, Massachusetts. 
Expertise: Toxicology; exposure assessment; health risk assessment; chemistry; chemical carcinogenesis; epidemiology.

Education: PhD in Food Science and Technology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts; BA in Chemistry, Wellesley College, Wellesley, Massachusetts. 

Experience Summary: Dr. Laura Green is senior toxicologist and president of Green Toxicology, LLC, and a part-time toxicologist with ARM Group, Inc.  She has practiced in the fields of toxicology and health risk assessment since 1978 and has been board-certified in general toxicology since 1988.  Dr. Green conducted research in chemical carcinogenesis and biochemical epidemiology at the Massachusetts Institute of Technology (M.I.T.) and was a part-time lecturer in environmental toxicology at M.I.T. for 25 years.  She also served as director of the Scientific Conflict Mapping Project at the Harvard School of Public Health.  Dr. Green has authored more than 160 reports related to toxicology and/or health risk assessment, as well as several book chapters, including the chapters "Drug Toxicity" and "Environmental Toxicology" in the textbook, Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy, 3rd and 4th editions (2011 and 2016).  She is also co-author of the book, In Search of Safety - Chemicals and Cancer Risk (Harvard University Press, 1988).  Dr. Green has also served as an invited peer-reviewer for the Agency for Toxic Substances and Disease Registry (ATSDR) and the U.S. Environmental Protection Agency(U.S. EPA), as well as for several scientific journals.
Panel Experience: Dr. Green served as an invited member of a U.S. EPA's Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Scientific Advisory Panel (SAP)  to evaluate the carcinogenic potential of glyphosate, a non-selective, phosphonomethyl amino acid herbicide (2016-2017).








                               MARIA T. MORANDI
Affiliation: Independent Consultant, Houston, Texas. 
Expertise: Occupational, consumer, and general exposure assessment; chemistry; volatile organics; disproportionately exposed populations; fiber science. 
Education: PhD in Environmental Health, New York University, New York; MS in Environmental Health, New York University, New York, New York; BS in Chemistry, City College of New York, New York, New York. 
Experience Summary: Dr. Maria Morandi is an independent consultant in exposure and environmental health since her retirement from academia. She has over 25 years of teaching and research experience as a Research Professor and Director of the Inhalation and Pulmonary Physiology Core at the University of Montana and as a member of the Environmental Sciences faculty at the University of Texas-Houston School of Public Health. She was certified in the comprehensive practice of industrial Hygiene (CIH; 1996 - 2016). Dr. Morandi was a member of the Committee on Acute Exposure Guideline Levels (AEGLs) of the National Research Council-National Academy of Sciences (2010 - 2014), the Board of Scientific Councilors of the National Toxicology Program (NTP; 2002 - 2006), the Mine Safety and Health Research Advisory (MSHRA) Committee (1998 - 2002) of the Centers for Disease Control and Prevention (CDC), and the Board of Scientific Councilors of the Agency for Toxic Substances and Disease Registry (ATSDR; 1994 - 1998). Her research interests focus on characterization and modeling of exposures in occupational and community settings, health effects from inhalation exposures, development of personal exposure monitors, characterization of indoor and outdoor air contaminants, and industrial hygiene. 
Panel Experience: Dr, Morandi is a member of the U.S. Environmental Protection Agency (U.S. EPA) Science Advisory Board (SAB) Scientific and Technological Achievement Awards Committee (STAA; 2019 - 2021). She has prior experience in federal panels include: Member and ad-hoc consultant to NIOSH's Safety and Occupational Health Study Session of the National Institute for Occupational Safety and Health (NIOSH; 1996 - present); member of the EPA-SAB Chemical Assessment Advisory Committee (CAAC; 2012 - 2018); member of the U.S. EPA's Clean Air Scientific Advisory Committee (CASAC) Ozone Review Panel (2007 -  2011), member of the U.S. EPA-SAB Integrated Human Exposure Assessment/Health Effects Committee (1992 - 1998 and 2003 - 2009); member of the U.S. EPA-SAB Research Strategies Advisory Committee (2002 - 2005); member, peer review panel for the U.S. EPA's STAR Fellowships in Public Health (2012 - 2013); reviewer, Small Business Innovative Grants (SBIR), National Institutes for Occupational Safety and Health and the National Institutes of Health (1998 - 2007); member, peer review panels for the U.S. EPA draft Report on the Environment in 2007 and 2004; member, Community Based Participatory Research Review Panel, National Institute of Environmental Health Sciences (2005 - 2008); Chair, peer review panel for the Human Exposure Research Program of the U.S. EPA-ORD (2001). Dr. Morandi also served in multiple review panels at the international, national, state, and local levels. 
                                EMANUELA TAIOLI
Affiliation: Director, Institute for Translational Epidemiology; Associate Director, Population Science; Program Director, Cancer Prevention & Control, Icahn School of Medicine at Mount Sinai, New York.

Expertise: My expertise is in the area of cancer epidemiology; environmental carcinogens, cancer and nutrition, and genetic susceptibility to cancer, genetic susceptibility to environmental exposure, cancer survivorship, health disparity, access to care in minorities, and chronic diseases prevention.

Education: MD, University of Milan, School of Medicine, Milano, Italy; PhD in Epidemiology, Columbia University School of Public Health, New York, New York.

Experience Summary: Dr. Emanuela Taioli is the Director of the Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai. She has conducted extensive research in the World Trade Center cohort. As Associate Director of Population Science, Dr. Taioli oversees the epidemiological, behavioral and health service research activities of the Tisch Cancer Institute at Mount Sinai. Dr. Taioli also co-leads the Cancer Prevention and Control Program. Among her most important contributions are those to the field of cancer prevention, including the study of cancer risk factors in healthy populations, cancer predisposing factors, hormone metabolism and genetic susceptibility to environmental exposure. She is a well-recognized expert in cancer survivorship and the effect of lifestyles changes on the risk for cancer recurrence and the development of secondary cancers. She has worked extensively on health disparities, access to care and chronic disease prevention in minority populations. She is a Scientific Board Member of the Mesothelioma Foundation, and of the Member, International Association for the Study of Lung Cancer (IASLC) Mesothelioma Task Force.

Panel Experience: Dr. Taioli is currently a member of the U.S. Environmental Protection Agency (U.S. EPA) Toxic Substance Control Act Science Advisory Committee on Chemicals (TSCA SACC; 2015-present).  Dr. Taioli's experience on panels includes, Lung Cancer Foundation Granter review (2018-present); National Cancer Institute (NCI) Fellow Study Section (2011-present); National Institutes of Health (NIH) Cancer Health Disparities/Diversity in Basic Cancer Research (2011-present); NIH Specialized Programs of Research Excellence (SPORE) Special Emphasis Panel (2010-present); Permanent Member, American Cancer Society study section "Clinical Cancer Research, Nutrition and Epidemiology" (2008-present);Special Emphasis Panel NIH Study Section, Cancer Prevention (2008-present); National Institute of Environmental Health Sciences Superfund grant reviewer (2010-2013); Clinical Trials Grants review panel, Komen Foundation NY-standing member (2008-2010); EU Program VII reviewer (2004). She has been a member of the U.S. EPA's Science Advisory Board Review on Trimethylbenzenes (2014), and of the U.S. EPA's SAB PAH Mixtures Review Panel (2010).
